Cite
HARVARD Citation
Rouyer, M. et al. (2016). Effectiveness and safety of first-line bevacizumab plus FOLFIRI in elderly patients with metastatic colorectal cancer: Results of the ETNA observational cohort. Journal of geriatric oncology. 7 (3), pp. 187-194. [Online].